IP Library › Patent Application 19054530
Patent Application
App. No. 19/054,530

COMPUTER-ASSISTED MODELING FOR TREATMENT DESIGN

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
19/054,530
Abstract

Some embodiments include a computer-assisted method of biomedical treatment design. For example, a computer system can select a compound model associated with a candidate compound that is structured to bind to a biological target to modulate the biological target into achieving a therapeutic effect. The computer system can then identify a structural feature in the compound model as a hinge region that connects domains in the candidate compound. The computer system then determines a mutation process to introduce a mutation at the hinge region such that the mutation activates the candidate compound. The computer system then generates an updated compound model based on the mutation added to the candidate compound to present in a treatment design interface.

Claims (6)

1 . A computer-assisted method for designing biomedical treatment, comprising:

selecting a compound model associated with a candidate compound that is structured to bind to a biological target to modulate the biological target into achieving a therapeutic effect;

identifying a structural feature in the compound model as a hinge region that connects domains in the candidate compound;

determining a mutation process to introduce a mutation at the hinge region such that the mutation activates the candidate compound, wherein said determining is by matching the structural feature against a hinge region database storing at least an association between the mutation process and the structural feature;

generating an updated compound model based on the mutation added to the candidate compound to present in a treatment design interface; and

presenting the updated compound model as a lead candidate compound for a biomedical treatment.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 23, 2025
From: INFINITEBIO, INC.
To: HINGE THERAPEUTICS, INC.
Reel/Frame 070928/0619 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 23, 2025
From: FUTAMURA, AKIKO
To: INFINITEBIO
Reel/Frame 071019/0319 →